Evidence map›Paper›PMID 37852577›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2024

Pathologic-genomic correlation identified a novel variant in FN1 and established the diagnosis of recurrent fibronectin glomerulopathy in the kidney allograft.

Ibrahim Batal, Samih H Nasr, Surendra Dasari, Astrid Weins, Natalie Vena, Michael B Stokes, Krzysztof Kiryluk, Gerald B Appel

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Fibronectin Glomerulopathy: A First African Case Report.Case reports in nephrology and dialysis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ibrahim BatalDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA. Electronic address: ib234@cumc.columbia.edu.
Samih H NasrDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Surendra DasariDepartment of Health Science Research, Mayo Clinic, Rochester, Minnesota, USA.
Astrid WeinsDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Natalie VenaDivision of Nephrology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Michael B StokesDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.
Krzysztof KirylukDivision of Nephrology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Gerald B AppelDivision of Nephrology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Columbia University Irving Medical Center · USBrigham and Women's Hospital · USMayo Clinic · USMayo Clinic in Florida · US

Funding

Genetics and Immune Predictors for Recurrent Glomerular Diseases in the Kidney AllograftR01DK135671 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Ibrahim Batal · 2023 to 2026
$1.5M
NIDDK NIH HHS R01 DK135671
6 · The paper itself

Abstract

Fibronectin glomerulopathy is a rare inherited kidney disease, characterized by abnormal accumulation of fibronectin in the glomeruli. We report an exceptional case of recurrent fibronectin glomerulopathy first diagnosed in the kidney allograft. The presence of IgA staining in the native kidney biopsy and the reported family history of IgA nephropathy had led to initial pretransplant diagnosis of IgA nephropathy. At 4.5 years posttransplant, the patient presented with kidney insufficiency and minimal proteinuria. The allograft biopsy revealed glomerular deposits with very weak staining for immunoglobulins and vague filamentous material. Immunostaining for fibronectin was positive, and genetic studies showed a variant of unknown significance in the fibronectin 1 gene. Proteomic analyses of the glomeruli in the native kidney biopsy demonstrated large amount of fibronectin with abundant accumulation of the peptide synthesized by the detected variant. These findings established the diagnosis of recurrent fibronectin glomerulopathy secondary to a novel variant in the fibronectin 1 gene. This report sheds light on recurrent fibronectin glomerulopathy in the allograft, highlights the diagnostic pitfalls of the disease, and underscores the importance of pathologic-genomic correlation to establish the correct diagnosis.

Indexed as

Glomerulonephritis, IGAGlomerulonephritis, MembranoproliferativeAllograftsFibronectinsGenomicsHumansKidneyProteomicsFibronectinsfibronectin glomerulopathygeneticspathology

Identifiers

PMID37852577
PMCPMC10922351
OpenAlexW4387662344

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.